Carregant...
VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1
PURPOSE: The purpose of our study was to evaluate the therapeutic effect of VIP on human retinal endothelial cells (HREC) under high glucose conditions. Diabetes affects almost 250 million people worldwide. Over 40% of diabetics are expected to develop diabetic retinopathy, which remains the leading...
Guardat en:
| Publicat a: | Prostaglandins Other Lipid Mediat |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5242223/ https://ncbi.nlm.nih.gov/pubmed/27026343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prostaglandins.2016.03.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|